Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Inhaled Fluticasone Propionate Delivered as Monodisperse Aerosols
2008-002139-34Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluticasone propionate in asthma (2 arms), sponsored by Imperial College London. Primary endpoint: Systemic exposure to fluticasone propionate (AUC0–12h). Started Jun 2008; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-002139-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002139-34.